학술논문

Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal–regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice
Document Type
Article
Source
In: Bone. (Bone, April 2024, 181)
Subject
Language
English
ISSN
87563282